Reuters logo
5 个月前
BRIEF-aTyr Pharma qtrly net loss per share attributable to common stockholders $0.53
2017年3月16日 / 晚上8点28分 / 5 个月前

BRIEF-aTyr Pharma qtrly net loss per share attributable to common stockholders $0.53

March 16 (Reuters) - aTyr Pharma Inc

* Atyr pharma -continues to expect that its cash, cash equivalents and investments will be sufficient to fund its anticipated operations into q3 of 2018

* Atyr pharma announces fourth quarter and year-end 2016 operating results

* Qtrly net loss per share attributable to common stockholders$0.53

* Q4 earnings per share view $-0.63 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below